A CASE REPORT ON ELTROMBOPAG INDUCED VENOUS THROMBOEMBOLISM IN IMMUNE THROMBOCYTOPENIA
*Layana Roy, Hannah Joseph, Sreehari R. and Dr Chepsy C Philip
Eltrombopag is a (TPO)-receptor agonist. It is used in the management of condition called thrombocytopenia(ITP). Many recent literatures are indicating a increased risk of multiple thrombotic event after administration of Eltrobopag. A 20 year old young lady who was a recently diagnosed case of ITP presented with complaints of complaints of left sided headache which upon further evaluation was diagnosed as thromboembolism. This case study aims at creating awareness on cautious usage of TPO-RA in ITP.
Keywords: Eltrombopag, Immune Thrombocytopenia, Venous thromboembolism, Platelets, TPO-RA.
[Full Text Article]